Cargando…
Structures, Targets and Recent Approaches in Anti-Leishmanial Drug Discovery and Development
Recent years have seen a significant improvement in available treatment options for leishmaniasis. Two new drugs, miltefosine and paromomycin, have been registered for the treatment of visceral leishmaniasis (VL) in India since 2002. Combination therapy is now explored in clinical trials as a new tr...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Open
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103891/ https://www.ncbi.nlm.nih.gov/pubmed/21629509 http://dx.doi.org/10.2174/1874104501105010031 |